摘要 |
<p>Treatment and prevention of immunosuppression therapy-induced nephrotoxicity with neutral endopeptidases such as N-[N-[(L)-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)-methoxy]carbonyl]-2-phenylethyl]-L-phenylalanyl]-β-alanine and N-[2-mercaptomethyl-3-(2-methylphenyl)-propioyl]-methionine are disclosed.</p> |